LEADER 01141nam--2200409---450- 001 990003043610203316 005 20080108162049.0 010 $a0-7352-0197-8 035 $a000304361 035 $aUSA01000304361 035 $a(ALEPH)000304361USA01 035 $a000304361 100 $a20080108d2002----km-y0itay50------ba 101 $aeng 102 $aUS 105 $a||||||||001yy 200 1 $aOptions as a strategic investment$fLawrence G. McMillan 205 $a4. ed 210 $aNew York$cNew York Institute of finance$dcopyr. 2002 215 $aXXI, 1001 p.$cgraf., tab.$d24 cm 300 $aGlossario: p. 963-982 300 $aIndice: p. 983-1000 410 0$12001 454 1$12001 461 1$1001-------$12001 606 0 $aOpzione 606 0 $aSpeculazione finanziaria 676 $a332.63228 700 1$aMcMILLAN,$bLawrence G.$0109035 801 0$aIT$bsalbc$gISBD 912 $a990003043610203316 951 $aP11 777$bDISTRA 959 $aBK 969 $aDISTRA 979 $aDISTRA2$b90$c20080108$lUSA01$h1620 996 $aOptions as a strategic investment$91021543 997 $aUNISA LEADER 00804nam0-2200313---450 001 990009512780403321 005 20220620094950.0 010 $a2040154213$bpaperback 035 $a000951278 035 $aFED01000951278 035 $a(Aleph)000951278FED01 035 $a000951278 100 $a20120118d1982----km-y0itay50------ba 101 0 $afre 102 $aFR 105 $a--------001yy 200 1 $a<> enzymes$fGilbert Durand et Pierre Monsan 210 $aParis$cBordas$dC1982 215 $a352 p.$d24 cm 610 0 $aBiochimica 676 $aBSF-572$v22$zita 700 1$aDurand,$bGilbert$010430 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009512780403321 952 $aBSF-572-DUR-1$fSC1 959 $aSC1 996 $aEnzymes$9850531 997 $aUNINA